Dedicated Cancer Care
Comprehensive clinical evaluation, precise disease staging, and expert second opinions. We thoroughly review past biopsy, PET-CT, and lab reports to craft individualized, evidence-based treatment plans tailored to each patient's condition.
Evidence-based systemic chemotherapy delivered in a modern daycare facility. Administered using international safety standards, precise dosage calculations, central line/port access care, and rigorous side-effect management.
Cutting-edge checkpoint inhibitor therapies (such as anti-PD-1 / PD-L1 drugs) that empower the patient’s own immune system to recognize and destroy cancer cells effectively with lower systemic toxicity than conventional drugs.
Precision oral and intravenous drugs engineered to target specific molecular changes and genetic mutations present within tumor cells, blocking cancer growth while minimizing harm to healthy normal tissues.
Specialized hormone-blocking medication protocols primarily utilized for hormone-sensitive malignancies, such as ER/PR positive breast cancers and advanced prostate cancers, preventing disease recurrence and disease progression.
Advanced genomic profiling including Next-Generation Sequencing (NGS), liquid biopsy, and biomarker identification to match patients with targeted therapies, drug antibody conjugates (ADCs), and clinical trials.
Expert management of solid organ tumors (breast, lung, gastrointestinal, head & neck, and gynaecological cancers) alongside haematological malignancies like Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Leukaemia, and Multiple Myeloma.
Comprehensive palliative support focusing on symptom control, cancer pain management, nutritional guidance, fatigue management, and psychological counseling to enhance patient comfort and overall quality of life.
Structured long-term surveillance schedules, regular diagnostic follow-up scans, early detection of potential recurrence, organ health monitoring, and personalized wellness plans for cancer survivors.
Proactive screening packages for early detection of breast, cervical, oral, and colorectal cancers. Includes genetic counseling and risk stratification for individuals with a strong family history of malignancy.